Berlin, Germany · Founded 2023 · Privately Held (backing)
Developer of a precision oncology platform designed to advance cancer diagnostics through next-generation biomarker discovery. StratifAI is based in Berlin, Germany and was founded in 2023. It has raised $16.3 million.
Last price · $/share
—
Implied valuation
—
Total raised
$16.3M
Last round
—
Team — not yet on record
No current team members for StratifAI are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of StratifAI with a free account
·The complete investor list: 14 names
·Watch StratifAI: the Monday email on marks, rounds and moves
